- Home
- OGI vs TLSA Comparison
OGI vs TLSA Comparison
Compare OGI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- TLSA
- Stock Information
- Founded
- OGI 2013
- TLSA 2013
- Country
- OGI Canada
- TLSA United Kingdom
- Employees
- OGI N/A
- TLSA N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- OGI Health Care
- TLSA Health Care
- Exchange
- OGI Nasdaq
- TLSA Nasdaq
- Market Cap
- OGI 205.1M
- TLSA 196.1M
- IPO Year
- OGI N/A
- TLSA 2000
- Fundamental
- Price
- OGI $1.51
- TLSA $1.70
- Analyst Decision
- OGI
- TLSA
- Analyst Count
- OGI 0
- TLSA 0
- Target Price
- OGI N/A
- TLSA N/A
- AVG Volume (30 Days)
- OGI 486.7K
- TLSA 214.9K
- Earning Date
- OGI 12-17-2025
- TLSA 01-01-0001
- Dividend Yield
- OGI N/A
- TLSA N/A
- EPS Growth
- OGI N/A
- TLSA N/A
- EPS
- OGI 0.05
- TLSA N/A
- Revenue
- OGI $164,107,753.00
- TLSA N/A
- Revenue This Year
- OGI $59.31
- TLSA N/A
- Revenue Next Year
- OGI $15.12
- TLSA N/A
- P/E Ratio
- OGI $35.47
- TLSA N/A
- Revenue Growth
- OGI 50.01
- TLSA N/A
- 52 Week Low
- OGI $0.85
- TLSA $0.63
- 52 Week High
- OGI $2.08
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- OGI 37.99
- TLSA 40.73
- Support Level
- OGI $1.47
- TLSA $1.60
- Resistance Level
- OGI $1.75
- TLSA $1.81
- Average True Range (ATR)
- OGI 0.08
- TLSA 0.13
- MACD
- OGI -0.01
- TLSA -0.02
- Stochastic Oscillator
- OGI 12.50
- TLSA 23.40
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.